menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

A Potential Treatment for Parkinson's Disease Showing Safety and Tolerability

ReachMD Healthcare Image
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Comments
  • Overview

    While current treatments for Parkinson’s disease can alleviate symptoms, they often fail to address the underlying cause or halt disease progression. However, new findings from the 201 Trial have shown positive safety and tolerability for a small molecule medication called risvodetnib. Read more about the expected data to be presented at the 2024 American Academy of Neurology Annual Meeting.

Facebook Comments

Recommended
Details
Comments
  • Overview

    While current treatments for Parkinson’s disease can alleviate symptoms, they often fail to address the underlying cause or halt disease progression. However, new findings from the 201 Trial have shown positive safety and tolerability for a small molecule medication called risvodetnib. Read more about the expected data to be presented at the 2024 American Academy of Neurology Annual Meeting.

Facebook Comments

Schedule27 May 2024